LexDanaLexDanabeta
Inventor

Per Sauerberg

Inventor
Farum, DK

Overview

93→
Patents
1986–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 93 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds37%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07CAcyclic or carbocyclic compounds15%
A61KPreparations for medical, dental or toiletry purposes13%
C07KPeptides2%
C12NMicroorganisms or enzymes1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
11,033,499Tablet formulation comprising a GLP-1 peptide and a delivery agent202110,960,052Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl) amino) caprylic acid202110,947,180Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists202110,471,066Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists201910,278,923Oral dosing of GLP-1 compounds201910,266,577GLP-1 derivatives, and uses thereof201910,195,255GLP-1 derivatives and uses thereof201910,086,047Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid20189,993,430Tablet formulation comprising semaglutide and a delivery agent20189,855,274'Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists'20189,708,383'Double-acylated GLP-1 derivatives'20179,663,481'Phenoxy acetic acids and phenyl propionic acids as PPARδ agonists'20179,498,534'Derivatives of GLP-1 like peptides, and uses thereof'20169,278,123'Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid'20168,648,041'Double-acylated GLP-1 derivatives'20148,551,993'Phenoxy acetic acids as PPAR delta activators'20138,362,016'Phenyl propionic acids as PPAR delta activators'20137,968,723'Compounds, their preparation and use'20117,943,613'Compounds, their preparation and use'20117,943,612'Compounds that modulate PPAR activity, their preparation and use'20117,816,385'Dimeric dicarboxylic acid derivatives, their preparation and use'20107,709,528'Compounds, their preparation and use'20107,220,877'Compounds, their preparation and use'20077,202,213'Combination therapy using a dual PPAR-α/PPAR-γ activator and a GLP-1 derivative for the treatment of metabolic syndrome and related diseases and disorders'20077,129,268'Peroxisome proliferator activated receptor-active arylene acetic acid derivatives'20067,091,245'Compounds, their preparation and use'20067,067,530'Compounds, their preparation and use'20066,972,294'Compounds, their preparation and use'20056,869,967'Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives'20056,867,218'Compounds, their preparation and use'20056,723,731'Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)'20046,720,342'Heterocyclic compounds and their preparation and use'20046,703,401'Compounds, their preparation and use'20046,683,111'Compounds, their preparation and use'20046,602,901'Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)'20036,569,901'Alkynyl-substituted propionic acid derivatives, their preparation and use'20036,555,577'Compounds, their preparation and use'20036,534,517'Compounds, their preparation and use'20036,525,086'Compounds, their preparation and use'20036,509,374'Compounds, their preparation and use'20036,468,996'Substituted hetero-polycyclic compounds as PPAR and PPAR activators'20026,407,127'Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)'20026,369,055'Compounds, their preparation and use'20026,365,586'Compounds, their preparation and use'20026,353,018'Compounds, their preparation and use'20026,300,339'Compounds, their preparation and use'20016,284,771'Method for treating schizophrenia'20016,274,608'Compounds, their preparation and use'20016,248,781'Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)'20016,214,820'Compounds, their preparation and use'20016,083,957'Heterocyclic compounds and their preparation and use'20006,015,813'Heterocyclic compounds and their preparation and use'2000RE036375'Treatment of Alzheimer\'s disease using azacyclic compounds'19995,977,129'Azacyclic and azabicyclic substituted oxa- or thia-diazole compounds'19995,968,926'Antipsychotic method'19995,919,805'Hetrocyclic compounds and their preparation and use'19995,914,338'Heterocyclic compounds and their preparation and use'19995,773,452'Heterocyclic compounds and their use'1998RE035822'Heterocyclic compounds'19985,750,538'Method of treating hypercholesterolemia and related disorders'19985,741,788'Heterocyclic compounds and their preparation and use'19985,712,297'Piperdine compounds and their preparation and use'19985,679,686'Antipsychotic method'19975,677,313'Antipsychotic method'19975,663,182'Antipsychotic method'19975,658,932'Heterocyclic compounds and their preparation and use'19975,641,791'Heterocyclic compounds and their preparation and use'19975,591,755'Pyridinyl thiadiazolyl compounds for treating glaucoma'19975,578,602'Certain 1-azabicyclo[3.3.1]nonene derivatives and their pharmacological uses'19965,574,043'Certain [1,2,5-thiadiazol-4-yl]-1-azabicyclo [3.2.1]octane derivatives and their pharmaceutical uses'19965,571,826'Heterocyclic compounds and their preparation and use'19965,559,136'Treatment of Alzheimer\'s disease using azacyclic compounds'19965,559,138'Method of Treating Glaucoma Using Oxadiazolyl or Thiadiazolyl Tetrahydropyridines'19965,534,528'Thiadiazolyl tetrhydrpyridines for treating glaucoma'19965,527,813'Heterocyclic compounds and their preparation and use'19965,418,240'Heterocyclic compounds and their preparation and use'19955,414,009'Azabicyclo substituted oxa- or thia-diazole compounds'19955,376,668'Heterocyclic compounds'19945,356,912'3-(5-isoxazolyl)-1-methyl-1,2,3,6-tetrahydropyridine useful for treating Alzheimer\'s disease'19945,328,924'Heterocyclic compounds and their use'19945,328,925'Piperidine compounds and their use'19945,328,923'Heterocyclic compounds and use'19945,284,859'Piperidine compounds and their use'19945,264,444'Piperidine compounds and use'19935,262,427'3-substituted and optionally 1-substituted azacyclic or azabicyclic compounds, pharmaceutical compositions, thereof and their use as stimulants of cognitive functions'19935,260,311'Piperidine compounds and their use'19935,260,314'Certain 3-(1,2,5-oxa- or thiadiazol-4-yl)-1-azabicyclo [2.2.2]octanes having pharmaceutical properties'19935,043,345'Piperidine compounds and their preparation and use'19915,041,455'Piperidine compounds and their preparation and use'19915,025,027'Cyclic carbamate analogues of (+)-pilocarpine'19914,933,353'Lipophilically-substituted piperidine oxadiazolyl compounds and their use in stimulating cognitive functions (II)'19904,837,241'Lipophillically-substituted piperidine oxadiazolyl compounds and their use in stimulating cognitive functions'19894,608,378'Tetrahydroisoxazolo[4,5-c]pyridine derivatives useful in the treatment of malfunctions of the acetylcholine or muscarinic systems'1986

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1986–1999Based in Valby, DK· patent location history
1991–2021Patents assigned to NOVO NORDISK AS (74)· patent assignee history
1994Based in Sondervangsalle, DK· patent location history
1996–2021Based in Farum, DK· patent location history
2001–2004Patents assigned to REDDY RESEARCH FOUNDATION (9)· patent assignee history
2010–2013Patents assigned to HIGH POINT PHARMACEUTICALS LLC (7)· patent assignee history
2013–2017Patents assigned to SAUERBERG PER (4)· patent assignee history
2017–2021Patents assigned to VTV THERAPEUTICS LLC (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NOVO NORDISK AS741991–2021
REDDY RESEARCH FOUNDATION92001–2004
HIGH POINT PHARMACEUTICALS LLC72010–2013
SAUERBERG PERself42013–2017
VTV THERAPEUTICS LLC42017–2021
Locations
LocationPatentsSpan
Farum, DK661996–2021
Valby, DK261986–1999
Sondervangsalle, DK11994